ALT5 Sigma Corp
NASDAQ:ALTS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
ALT5 Sigma Corp
Depreciation & Amortization
ALT5 Sigma Corp
Depreciation & Amortization Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
ALT5 Sigma Corp
NASDAQ:ALTS
|
Depreciation & Amortization
$3.3m
|
CAGR 3-Years
81%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
10%
|
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Depreciation & Amortization
$7.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
7%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Depreciation & Amortization
$4B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
27%
|
|
|
|
Pfizer Inc
NYSE:PFE
|
Depreciation & Amortization
$6.6B
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
2%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Depreciation & Amortization
$5.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
11%
|
CAGR 10-Years
-1%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Depreciation & Amortization
$2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
|
ALT5 Sigma Corp
Glance View
JanOne, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. The company is headquartered in Las Vegas, Nevada and currently employs 5 full-time employees. The company went IPO on 2006-02-22. Through its fintech activities, it provides blockchain-powered technologies to enable a migration to a new global financial paradigm for the trading, clearing, settlement, payment, and custodianship of digital instruments. Through its fintech subsidiaries, it offers two main platforms to its customers: ALT5 Pay and ALT5 Prime. ALT5 Pay is a cryptocurrency payment gateway that enables registered and approved global merchants to accept and make cryptocurrency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Through its biotech activities, it is developing solutions intended to help end the opioid crisis.
See Also
What is ALT5 Sigma Corp's Depreciation & Amortization?
Depreciation & Amortization
3.3m
USD
Based on the financial report for Dec 27, 2025, ALT5 Sigma Corp's Depreciation & Amortization amounts to 3.3m USD.
What is ALT5 Sigma Corp's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
10%
Over the last year, the Depreciation & Amortization growth was -3%. The average annual Depreciation & Amortization growth rates for ALT5 Sigma Corp have been 81% over the past three years , -4% over the past five years , and 10% over the past ten years .
